GMTF, Atlantic Lifesciences explore local production of cancer and heart medicines
Ghana Medical Trust Fund (GMTF) is exploring a strategic partnership with Atlantic Lifesciences Limited and the PharmaNova Group to locally manufacture critical medicines for cancer, cardiovascular diseases and other chronic conditions.
The Ghana Medical Trust Fund (GMTF) is exploring a partnership with Atlantic Lifesciences Limited and the PharmaNova Group to produce essential medicines for cancer, cardiovascular diseases and other chronic conditions locally. This move could lower treatment costs for thousands of Ghanaians and alleviate Ghana's reliance on expensive medicine imports.
The initiative aligns with the GMTF's goal of obtaining essential medicines at more affordable prices, reducing the Trust Fund's dependence on costly imports and maximizing the impact of every cedi allocated to the Fund. The GMTF Administrator, Adjoa Obuobia Darko-Opoku, led a team to visit Atlantic Lifesciences to assess its facilities, capabilities and potential collaboration areas.
The discussions revolved around identifying how Ghana could produce life-saving medicines more affordably while reducing the burden of imported medicines on the healthcare system. A statement from the GMTF highlighted the potential benefits of local manufacturing, including reduced import-related costs, improved availability of essential drugs and increased capacity to support a larger number of patients battling chronic and life-threatening diseases.
The initiative also supports the government's vision of strengthening Ghana's pharmaceutical manufacturing capacity and building a more resilient and self-sufficient healthcare system. Dhanankay Tripathi, CEO of PharmaNova Ltd., emphasized the importance of addressing gaps in Ghana's healthcare system and developing practical solutions that meet patients' needs.
The GMTF team's visit to Atlantic Lifesciences provided them with a firsthand look at the company's operations, manufacturing capabilities and potential contribution to the Trust Fund's mission. The collaboration aims to deepen partnerships between the GMTF and pharmaceutical companies, healthcare providers and other organizations capable of bringing expertise, resources and innovative solutions to the fight against chronic diseases.
The Trust Fund's objective is to find sustainable ways to lower treatment costs, expand access to life-saving medicines and maximize the impact of every Trust Fund contribution, ultimately supporting more patients and contributing to a stronger and more affordable healthcare system for Ghana.
Written by urgent.news from MyJoyOnline Ghana's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
